Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.5588 | 1 | 1 |
Echinococcus multilocularis | alpha 1,6 mannosyl glycoprotein | 0.5588 | 1 | 0.5 |
Schistosoma mansoni | beta-12-n-acetylglucosaminyltransferase II | 0.5588 | 1 | 0.5 |
Echinococcus granulosus | alpha 16 mannosyl glycoprotein | 0.5588 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 25 % | Effect on metacholine-induced bronchoconstriction in mouse assessed as bronchoprotection at 5 ug after 24 hrs | ChEMBL. | 17911022 |
Activity (functional) | = 80 % | Effect on metacholine-induced bronchoconstriction in mouse assessed as bronchoprotection at 5 ug after 5 hrs | ChEMBL. | 17911022 |
Activity (functional) | = 85 % | Effect on metacholine-induced bronchoconstriction in mouse assessed as bronchoprotection at 5 ug after 15 mins | ChEMBL. | 17911022 |
IC50 (functional) | = 2 nM | Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization | ChEMBL. | 17911022 |
IC50 (functional) | = 2.1 nM | Antagonist activity at cloned muscarinic M1 receptor expressed in CHO cells by measuring calcium mobilization | ChEMBL. | 17911022 |
IC50 (functional) | = 10.9 nM | Antagonist activity at cloned muscarinic M2 receptor expressed in CHO cells by measuring calcium mobilization | ChEMBL. | 17911022 |
Ratio IC50 (binding) | = 1 | Selectivity for cloned muscarinic M3 receptor over cloned muscarinic M1 receptor | ChEMBL. | 17911022 |
Ratio IC50 (binding) | = 5.5 | Selectivity for cloned muscarinic M3 receptor over cloned muscarinic M2 receptor | ChEMBL. | 17911022 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.